MGM Resorts plans to stop covering GLP-1 weight loss shots for its employees next year, after it faced constraints in what it ...

The promise of a one-and-done CRISPR in­fu­sion is be­gin­ning to look more re­al than ever. On Thurs­day, In­tel­lia ...

GSK is presenting its case for broader use of its RSV vaccine with new data from a pair of studies in younger adults with ...

Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...

Precision Biosciences has received clearance from regulators in the Eastern European country of Moldova to begin a human ...

Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval ...

More people are now advised to get a pneumococcal vaccine if they haven’t already, as CDC advisors recommended the shots for ...

Antitrust regulators shouldn't clear Novo Holdings' planned acquisition of Catalent, Roche CEO Thomas Schinecker said ...

Thermo Fisher told investors it is ready to shut the door on 2024, anticipating biotech funding to improve and lingering ...

A venture capital firm that seeks to digitize the life sciences ecosystem has plans for a $500 million follow-up fund, ...

Alto Neuroscience’s stock tumbled 60% on Wednesday morning, the day after the company said a mid-stage trial for its oral ...

Eccogene's $60M milestone from AstraZeneca: The payment arrived after Eccogene met several milestones, including dosing the first ...